A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patients. (Record no. 18003409)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01962 a2200613 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515122416.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200806s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0959-4973 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1097/cad.0b013e3282f46aec |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Validire, Patricia |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20080619 |
245 00 - TITLE STATEMENT | |
Title | A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patients. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Anti-cancer drugs |
Date of publication, distribution, etc. | Mar 2008 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 309-15 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Multicenter Study |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adolescent |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged, 80 and over |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Deoxycytidine |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease Progression |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Dose-Response Relationship, Drug |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Resistance, Neoplasm |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hemoglobins |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hodgkin Disease |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasm Staging |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prognosis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Recurrence |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Remission Induction |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Retrospective Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gemcitabine |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Fermé, Christophe |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Brice, Pauline |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Diviné, Marine |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gabarre, Jean |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bouabdallah, Krimo |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Fitoussi, Olivier |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Chaoui, Driss |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pacquement, Hélène |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Soussain, Carole |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Carde, Patrice |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Salhi, Rafika |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zanni, Manuela |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Decaudin, Didier |
773 0# - HOST ITEM ENTRY | |
Title | Anti-cancer drugs |
Related parts | vol. 19 |
-- | no. 3 |
-- | p. 309-15 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1097/cad.0b013e3282f46aec">https://doi.org/10.1097/cad.0b013e3282f46aec</a> |
Public note | Available from publisher's website |
No items available.